Pliant Therapeutics Inc

NASDAQ:PLRX   4:00:00 PM EDT
14.55
+0.41 (+2.90%)
: $14.55 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)876.48M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.58 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$14.70
50-Day MA$16.15
200-Day MA$16.65
See more pivots

Pliant Therapeutics Inc Stock, NASDAQ:PLRX

260 Littlefield Avenue, South San Francisco, California 94080
United States of America
Phone: +1.650.481.6770
Number of Employees: 158

Description

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-Ã?Å?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.